Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
2.990
+0.180 (6.41%)
At close: Dec 20, 2024, 4:00 PM
3.050
+0.060 (2.01%)
After-hours: Dec 20, 2024, 5:34 PM EST
Inozyme Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -96.49 | -71.17 | -67.06 | -56.62 | -56.42 | -19.72 | |
| Depreciation & Amortization | 0.77 | 0.83 | 0.74 | 0.67 | 0.22 | 0.08 | |
| Loss (Gain) From Sale of Assets | 0.02 | 0.02 | 0.02 | - | - | - | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 17.76 | - | |
| Loss (Gain) From Sale of Investments | -6.6 | -5.44 | -1.67 | 0.17 | 0.28 | -0.07 | |
| Stock-Based Compensation | 7.65 | 7.04 | 7.67 | 7.16 | 2.31 | 0.3 | |
| Other Operating Activities | 1.62 | 1.12 | 0.53 | 0.38 | - | - | |
| Change in Accounts Payable | 0.2 | -1.38 | 0.15 | -0.68 | 2.1 | -0.08 | |
| Change in Other Net Operating Assets | 1.62 | -1.7 | 1.86 | 0.76 | -2.21 | 0.68 | |
| Operating Cash Flow | -91.21 | -70.68 | -57.76 | -48.15 | -35.97 | -18.81 | |
| Capital Expenditures | -0.15 | -0.3 | -0.41 | -0.4 | -0.57 | -0.14 | |
| Investment in Securities | 45.24 | -53.35 | -4.99 | 43.19 | -116.61 | -8.25 | |
| Investing Cash Flow | 45.09 | -53.65 | -5.4 | 42.8 | -117.18 | -8.39 | |
| Long-Term Debt Issued | - | 40 | 4.05 | - | - | - | |
| Net Debt Issued (Repaid) | 12.5 | 40 | 4.05 | - | - | - | |
| Issuance of Common Stock | 11.16 | 85.97 | 68.74 | 0.61 | 116.17 | 0.07 | |
| Financing Cash Flow | 23.66 | 125.97 | 72.79 | 0.61 | 149.81 | 22.97 | |
| Foreign Exchange Rate Adjustments | 0.14 | -0.02 | -0.03 | 0.02 | - | - | |
| Net Cash Flow | -22.32 | 1.63 | 9.6 | -4.72 | -3.34 | -4.23 | |
| Free Cash Flow | -91.36 | -70.97 | -58.17 | -48.55 | -36.54 | -18.95 | |
| Free Cash Flow Per Share | -1.47 | -1.37 | -1.54 | -2.06 | -3.31 | -16.02 | |
| Cash Interest Paid | 2.35 | 2.35 | 0.17 | - | - | - | |
| Levered Free Cash Flow | -55.93 | -46.05 | -32.07 | -27.29 | -29.91 | -12.14 | |
| Unlevered Free Cash Flow | -52.54 | -43.96 | -31.9 | -27.29 | -29.91 | -12.14 | |
| Change in Net Working Capital | -1.48 | 4.26 | -3.01 | -0.67 | -3.78 | -0.62 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.